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Household-based interventions are a mainstay of public health
policy against epidemic respiratory pathogens when vaccination
is not available. Although their efficacy has traditionally been
measured by their ability to reduce the proportion of household
contacts who exhibit symptoms (hSAR), reduction in hSAR is not
easy to interpret for households of different sizes and makes only
partial use of data collected by modern field studies. Here, we
use Bayesian transmission model inference to analyze jointly both
symptom reporting and viral shedding data from a three-armed
study of influenza interventions. The reduction in daily hazard
of infection in the increased hand hygiene intervention arm was
37.0% [8.3%, 57.8%] compared with the control arm, while the
equivalent reduction in the intervention arm that increased hand
hygiene and used face masks was 27.2% [-0.46%, 52.3%]. By
imputing the presence and timing of unobserved infections, we
estimated that only 61.7% [43.1%, 76.9%] of infections met the
case criteria and were thus detected by the study. Compared to
adults, children were 2.29 [1.66. 3.23] times as infectious and 3.36
[2.31, 4.82] times as susceptible. The mean generation time was
3.39 days [3.06, 3.70]. Laboratory confirmation of infections by
RT-PCR was only able to detect 79.6% [76.5%, 83.0%] of symp-
tomatic infections, even at the peak of shedding. Examination of
the posterior distribution of inferred infections in the three inter-
vention arms was revealing. It suggested that stochastic variation
in the timing and levels of followup between arms led to a lower
rate of detection of infections in the control arm than was the case
in the intervention arm and thus a reduced estimate of interven-
tion efficacy based only on observed hSAR. Our results highlight
the potential use inferential transmission models to improve the
design of household-based intervention studies.
Non-pharmaceutical interventions | Household transmission dynamics |
Bayesian inference | Markov Chain Monte Carlo
The household offers an ideal setting to study the transmission dy-namics of viral respiratory pathogens [1, 2, 3, 4, 5] and, during
periods of severe epidemics, to intervene and reduce the number of
infections [6]. Therefore, it is also the ideal setting in which to con-
duct trials of interventions designed to reduce infectivity and suscep-
tibility. The known-index trial design has been used to measure the
efficacy of different types of intervention in recent years, including
non-pharmaceutical interventions [7, 8, 9] , antivirals [10] and vac-
cines [11, 12, 13]. In these studies, symptomatic individuals are re-
cruited at a health care facility and asked if they − and potentially
other members of their household − may want to participate in the
trial. If the index agrees, biological samples are taken at that time in
the clinic. Followups normally occur in the household, with the first
visit as soon after the recruitment of the index as possible. If other
members of the household agree to participate, samples are taken at
regular intervals after that first followup from the index and additional
participating household members. Biological samples used in these
studies include nasal or throat swabs, nasopharyngeal aspirates and
blood samples. Many different assays can be conducted on the sam-
ples (depending to some extent on the sample handling protocol), for
example; rapid tests [14], RT-PCR [15, 7], and B-cell assays [16].
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Fig. 1: Proportions of household members meeting case criteria (us-
ing a composite definition based on symptoms and RT-PCR results)
in different intervention groups and for different delay intervals be-
tween the time of symptom onset the of index case and recruitment
into the study. 95% confidence intervals are represented by vertical
bars. To aid direct comparison with previous work XX cite XX, these
estimates excluded the 63 households in which the index patient did
not have RT-PCR-confirmed infection or a household contact had RT-
PCR-confirmed infection at the initial household visit.
Participants may also be asked to record symptoms in a diary or to
report them over the phone.
Significance
Traditionally, the efficacy of household-based non-
pharmaceutical interventions against influenza is measured
by the household secondary attack rate (hSAR) based on
observed individual epidemiological data. We present an al-
ternative measure of intervention efficacy that accounts for
unobserved transmission using Bayesian techniques. We apply
our methods to data from a study of household interventions
(facemasks and improved hand hygiene) in Hong Kong. This
paper describes advances in our understanding of an important
disease system and also our statistical ability to synthesise
modern data streams.
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Table 1: Estimates of key model parameters.
Parameters Posterior Mean (95% C.I.)
Half-life of the infectiousness profile, aeff 3.86 [3.04, 4.43]
Time (day) of peak infectivity, b 1.50 [0.52, 2.42]
Infectivity of children per day, β1 2.91 [2.13, 3.65]
Infectivity of adults per day, β2 1.27 [0.83, 1.79]
Susceptibility of children relative to adults, η1 3.36 [2.31, 4.82]
Peak level of RT-PCR test sensitivity, ψ 79.6% [76.5%, 83.0%]
Intervention efficacy per day for HH only, r2 37.0% [8.3%, 57.8%]
Intervention efficacy per day for HH + FM , r3 27.2% [-4.6%, 52.3%]
The primary outcome measure for these trials is the household
secondary attack rate (hSAR) (sometimes called secondary infection
risk). The hSAR is most commonly defined as the proportion of
non-index household members who become cases according to pre-
specified criteria, during the period of the study. Cases are usually de-
fined in terms of either symptoms or virological outcome (e.g. PCR-
confirmed infection), or sometimes both [7]. Although significant re-
ductions in hSAR between study arms are indicative of an effect, the
amplitude of differences in hSAR can be difficult to interpret, partly
because the statistic itself is dependent on the assays used and on the
precise followup protocol. For example, criteria based on symptoms
may fail to capture asymptomatic infections while RT-PCR tests are
sensitive to the frequency and timing of sampling. Also, the observed
value of the hSAR in any specific household must be sensitive to the
number of household members who participate, the precise timing of
followup samples and the pattern of any drop out.
XX this bit needs to cite Ira and Betz’ work as well XX By spec-
ifying a transmission process model for each household and estimat-
ing the parameters of that model given the data, it has been possible
to overcome some of these challenges for observational studies (e.g.
[17, 3]). Here, we extend these previously developed methods to in-
corporate symptom-based endpoints and repeat PCR-status, and the
effect of interventions. We defined a stochastic household transmis-
sion model that described the effect of interventions in reducing the
daily hazard of infection and estimated parameters of the model us-
ing Markov chain Monte Carlo (McMC) techniques (see Materials
and Methods and Supplementary Information (SI)).
Results
Study Data. We analyse a super-set of data from 322 households par-
ticipating in a previously described known-index intervention study
of influenza [7, 14]. Three hundred and twenty-two of these were
included in the primary analysis and randomly assigned to one of
three groups; control (112 households), intervention with improved
hand hygiene (HH, 106 households), or intervention with improved
hand hygiene plus facemasks (HH+FM, 106 households) [7]. Each
index case was initially screened by rapid test and confirmed using
PCR. Non-index household members were defined to be cases if they
were PCR-confirmed on or after the second visit or if they showed
at least 2 of the following signs and symptoms; temperature above
37.7 ◦C, cough, headache, sore throat, or myalgia [7, 18]. Using tra-
ditional hSAR as the outcome for the primary analysis, a significant
difference was observed between the control and HH arms, but only
for a subset of households in which the index case attended clinic
rapidly after the onset of symptoms (Figure 1, see also Figure S1)
[7]. Data from the 63 additional households included here could not
be included in the primary analyses because either the index was not
confirmed as infected by PCR (n=16, despite being positive on rapid
test) or because a household contact had RT-PCR-confirmed infection
at the initial household visit (n=47, defined to be co-primary) [7].
Parameter Estimation and Validation. We defined a process model
for the transmission of influenza in a study household, with param-
eters that would allow us to make inference on the efficacy of in-
terventions and underlying dynamics (see Materials and Methods).
We sampled from the joint posterior distribution of: number of in-
fections, times of infection, and process parameters of interest (Table
1); conditional on the full set of study results and (mainly) uninfor-
mative prior distributions. The posterior distributions of model pa-
rameters are shown in Figure S3. With the modal posterior values for
the model parameters, we simulated study outcomes using the pre-
cise study protocol for each household and obtained distributions of
hSAR consistent with the observed data (Tables S1 and S2). Also, for
validation, we used multiple sets of these pseudo-data to successfully
re-estimate the modal process parameters (Table S3).
Household transmission dynamics. We estimated that, in this study,
children were substantially more susceptible and infectious than were
adults (Table 1). The infectiousness parameters for children and
adults in the model are defined relative to the household size and are
therefore somewhat difficult to assess directly. However, their ratio is
easier to interpret, with children 2.29 [1.66. 3.23] times as infectious
as adults and 3.36 [2.31, 4.82] times as susceptible. These results
are broadly consistent with prior studies based only on symptomatic
outcomes [2, 3, 22].
The basic functional form of the infectiousness over time was as-
sumed to be the log-normal density function truncated at day 10 (see
Materials and Methods). Figure 2A shows how the inferred ampli-
tude of infectiousness varies over the time since infection for house-
holds of size 4. It was necessary to consider a specific household size
because we assumed that pair-wise infectiousness between individu-
als could vary as a function of household size, i.e. as the size of the
household increased, the probability of infection between each possi-
ble susceptible-infectious pair was not constant. These infectiousness
profiles contrast somewhat with previous results [17] based only on
symptoms. While Ref [17] and our results both suggest that infec-
tiousness is highest near the day of symptoms, our estimated profiles
exhibit a fatter tail than that in Ref [17].
To give a more intuitive description of the infectivity profiles, we
also calculated the pairwise transmission probabilities (see SI 1.1.3)
of children and adults over the full period of their infectiousness, in
the absence of interventions. Figure 2B and 2C shows the absolute
and relative comparison between pairwise transmission probabilities
of children and adults in different household sizes.
The generation time is defined as the expected delay between the
infection of an infector and the infection of all their infectees across
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Fig. 2: Infectivity profiles and pairwise transmission probabilities. A. Estimated infectiousness over time, assuming household size 4 (median
household size in data); vertical bars show 95% credible intervals. B. Estimated pairwise transmission probabilities for different household
sizes. C. Estimated pairwise transmission probabilities for children relative to adults.
all infection types [25]. Leveraging our ability to infer infection
events, we were also able to estimate the approximate generation time
commonly reported from household studies − the time between the
infection of the index case and the infection of the secondary cases.
We estimated this to be 3.39 days [3.06, 3.70] (Figure S2) which was
consistent with estimates in the literature for this and other strains of
influenza A [26, 29].
Intervention Efficacy. Intervention efficacy was modelled as the per
day reduction of infectiousness and could take a different value in
each of the three study arms. Using all available data, the efficacy
in the HH group was estimated to be significantly different from 0
at 37.0% [8.3%, 57.8%] and for HH+FM was 27.2% [-4.6%, 52.3%]
(Table 1). Although the reduction in infectivity was not significant
for individual days, the cumulative effect reflected in the overall re-
duction in pair-wise transmission probability was significant (Figure
3).
By inferring the presence or absence of infections during the period
of the study for all members of participating households (see Mate-
rials and Methods), we were able to compare the directly observed
hSAR with an inferred hSAR. We estimated that only 61.7% [43.1%,
76.9%] of infections that occurred in households during the period of
the study met the case criteria (see Study data). The underestimation
was driven by variable timing of followup and also by variable sen-
sitivity of the RT-PCR test, depending on the number of days since
infection [19, 20, 21].
When the data were stratified by the delay between symptom onset
in the index case and the interventions (i.e the speed of intervention),
the inferred hSARs described a more coherent story than the crude
hSARs, with, in particular, higher numbers of infections being in-
ferred in the control arm than would have been expected from the ob-
served hSARS for delays of 2 days or greater (Figure 4). Although the
structural assumptions implicit in our model (see Discussion) must
have constrained the inferred infection events to some degree, it is
encouraging that the two interventions had similar efficacy for each
delay strata and that the pattern of increasing efficacy with reducing
delay was consistent. The differences between inferred and observed
hSAR were likely driven by stochastic variation in the timing and
frequency of followup between households.
RT-PCR Test Sensitivity.RT-PCR is the gold standard laboratory
method for confirming viral respiratory infections among symp-
tomatic individuals. We estimated the peak level of RT-PCR test
sensitivity in this field study to be 79.6% [76.5%, 83.0%] for symp-
tomatic infections. This estimate is fundamentally different from pre-
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Fig. 3: Reduction of the pairwise transmission probability after inter-
ventions in the two different intervention arms (assuming household
size 4)
vious estimates because it incorporates both uncertainty about the true
state of the individual as well as the performance of the sampling
protocol and assay themselves. Although the relative sensitivity of
asymptomatic infections was not identifiable in this analysis and was
assumed to be half that of symptomatic infections [24], key model
parameters appeared to be robust towards these assumptions (see Sen-
sitivity Analysis).
Sensitivity Analysis. In our baseline analyses we assumed a Gamma
distribution for the incubation period with mean 2 days and standard
deviation 0.2 days [37]. Two alternative incubation period incubation
periods were adopted: a Weibull distribution with mean 1.48 days
and standard deviation 0.47 days [17], and a Lognormal distribution
with median 1.4 days and dispersion factor 1.51 days [38]. We also
tested the robustness of the assumptions over the ratio of the sensi-
tivity of RT-PCR testing between asymptomatic infections and symp-
tomatic infections S2/S1. The value of the nuisance parameter φ
(non-infection symptoms onset rate, see Materials and Methods) was
assumed to be 0.001 (Refs [35, 36]) and was varied in this sensitivity
analysis. The parameters including the intervention efficacy param-
eters appear to be robust towards the assumptions (see Figure S3 to
S6).
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Fig. 4: Posterior densities of the rates of secondary infection in dif-
ferent study arms with different days of delay to intervention. The
distributions of the inferred hSAR (i.e. hSAR inferred from imputing
the hidden infection process including the number of infections) are
represented by solid curves. Dotted lines represent the hSAR based
on original case criteria (i.e. the crude hSAR)
Also, we show the distribution of the generation time (last panels
in the Figure S3 to S6) and the distribution of the percentage of in-
fections meeting case criteria (Table S4), obtained by inferring the
hidden infection process. They appeared to be more sensitive to the
assumption of the ratio of the sensitivity of RT-PCR testing between
asymptomatic infections and symptomatic infections S2/S1 but were
fairly robust in most scenarios. In particular, the distributions of gen-
eration time were still consistent with the range suggested in the lit-
erature [26, 29].
Optimization of Study Design. We used our estimated process model
parameters to examine some specific issues around trial design. We
designed a simulation experiment to explore how the timing of mea-
surements (i.e. the timing of performing RT-PCR tests) may affect
the outcome of the traditional analysis. Specifically, we answered the
following question: if it was only possible to make a single visit to
each household in order to evaluate an intervention (perhaps due to
logistic constraints or cost-effectiveness considerations) what would
be the best day to visit the household so that difference of number
of infections (between intervention arms and control arm) may be
more genuinely reflected by the traditional analysis? Based on the
transmission-dynamic parameters estimated here, we simulated ob-
servations from our estimated model and assumed that only one home
visit was carried out. To eliminate the effect due to the time of imple-
menting the interventions, we only considered households with initial
home visit within the same day as the symptoms onset of the index
case. We found that a single sample at day 5 would have the high-
est expected difference in observed PCR-confirmed hSAR (Figure 5).
A single sample at day 4 would have a very similar expected differ-
ence between interventions and control but greater variance, suggest-
ing that in day 4 or day 5 we may have most “detectable” infections
circulating in households.
Discussion
We incorporated both viral shedding data and symptomatic data into
a transmission model that allowed the estimation of the efficacy of
interventions and key epidemiological parameters. Our analysis re-
fines the primary study analyses in estimating a significant effect in
one intervention arm using data from all households, rather than data
only from a (pre-specified) subset, highlighting opportunities to im-
prove on traditional measures such as the observed hSAR [7]. We
showed that intervention efficacy can be more accurately captured
using a disease dynamic model coupled with rigorous statistical in-
ference. Also, by inferring the number and timing of infections,
the underlying transmission dynamics could also be described and
the impact of variable timing of interventions in household assessed.
Subject to structural biases, we argue that this approach extracts sub-
stantial additional information from known-index transmission stud-
ies than does traditional analysis reliant on the hSAR. More generally,
our results highlight the potential use of robust inference with well-
designed mechanistic transmission models to improve the design of
intervention studies.
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Fig. 5: Based on the transmission-dynamic parameters estimated
here, we simulated observations from our estimated model and as-
sumed that only one home visit was carried out. To eliminate the
effect due to the time of implementing the interventions, we only con-
sidered households with initial home visit within the same day as the
symptoms onset of the index case. We computed the simulated differ-
ence of RT-PCR-positive between HH group and control group. We
considered seven scenarios in which the home visit was carried out
respectively at day 0, day 1, day 2, day 3, day 4, day 5 and day 6
since the symptoms onset of the index cases.
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Compared to other non-pharmaceutical interventions, such as quar-
antine and social distancing, the use of facemasks and improved hand
hygiene are simple and imposes less burden on those infected and
their contacts. Our results have helped to re-enforce earlier findings
of substantial efficacy. Also, we suggest that defining the estimated
efficacy as a per day reduction in transmission gives a more inter-
pretable measure and could be a useful quantity to communicate as
part of an overall health protection message.
Our study has a number of limitations associated with the struc-
tured assumptions implicit in our model. First of all, we only es-
timated the average efficacy of improved hand hygiene and face-
masks by aggregating other heterogeneities such as adherence and
age distribution among the households. Nonetheless, adherence to
hand hygiene intervention (i.e. the main contributing intervention in
our study) was similar to that reported in previous community stud-
ies [30, 31, 32]. Hence, although the estimated intervention efficacy
should have varied with different adherence, the similarity of the ad-
herence between our study and that in other community studies sup-
ports some generalization of our findings the practicality of our con-
clusion.
We were not able to simultaneously estimate the reduction of ab-
solute susceptibility and the reduction of infectivity due to interven-
tions, as they were not identifiable with each other. Instead, to avoid
this issue of identifiability, our model was parameterized by the rel-
ative susceptibility of children and we estimated the reduction of in-
fectivity. Children and adults were assumed to be subject to a com-
mon community infection rate which may only represent a relatively
crude average measure. However, as the study design aimed to re-
cruit households which had infections mostly initiated by the index
cases, the data may not be able to inform the community infection at
a finer resolution. Nevertheless, the estimated common community
infection rate appeared to be insignificant and hence was believed not
have a significant impact (see SI).
A parallel analysis of these data using a different approach found
evidence suggestive that aerosol (small droplets) transmission might
be responsible for approximately half of all influenza transmission
in households [28]. Our results are consistent with this finding,
since only a small to medium effect of face masks and hand hygiene
would be expected given that they are thought to reduce transmission
via large droplets and contact. Further extensions of our modelling
framework could be considered in the future to account for different
modes of transmission.
Although there is some evidence that children might have a higher
level and a longer duration of shedding [33, 26] compared with adults,
we assumed the same underlying function. Also, we only estimated
the sensitivity of RT-PCR as a function of time since infection and it
was assumed to peak between 2 to 5 days after infection (i.e. around
the mean time of symptoms onset) [34]. A more direct factor affect-
ing the test sensitivity may be the viral shedding [19, 20, 21]. Future
work in linking viral shedding explicitly with the test sensitivity could
further refine the approach we have used here.
Our framework can be utilized to answer specific questions related
to trial design as well as to conduct secondary analysis of existing
data. Here, we illustrated this by estimating the best possible day
for a single followup visit in an interventions trial. However, a more
systematic trial design study with well defined resources that may be
constrained may well produce far more efficient protocols, perhaps
varying by household size and age distribution.
Materials and Methods
Details of Data Collection.In 2008, from 2 January through 30
September, 407 index patients with influenza-like illness with symp-
tom onset in the previous 48 hours and who were positive for in-
fluenza A or B virus by QuickVue Influenza A+B rapid testing were
recruited at outpatient clinics in Hong Kong. Households with fewer
than 2 members or those with members reporting influenza-like ill-
ness in the preceding 14 days were excluded. There were, in total,
322 eligible households who agreed to participate. The households
were randomly assigned to one of the three groups: control group
(n = 112 households), intervention group with improved hand hy-
giene (n = 106) and intervention group with facemasks and im-
proved hand hygiene (n = 106). The intervention was carried out
in an initial home visit scheduled within 2 days after the randomiza-
tion. Demographic data, nasal and throat swab specimens from all
household members who were 2 years of age or older were collected
during the home visit. All household contacts were required to keep
daily symptom diaries within the observational period after the initial
intervention. Further nasal and throat swab specimens from all house-
hold members were collected in subsequent home visits which were
scheduled usually around 3 and 6 days after the initial visit. More
details on the study design can be found in a previous paper [7].
Transmission Model.We developed a stochastic model to jointly
capture: the study design, the transmission process and the efficacy of
the interventions. Household members were classified by their ages
(i.e. children and adults) and otherwise identical.
There were four major components to be explicitly modelled: (un-
observed) infection times, symptom onset times, RT-PCR test results
and the intervention efficacy. Here, we describe the assumed pro-
cesses related to each of these components. Each infected member
was assumed to exhibit time-varying infectivity (i.e. hazard of in-
fection) since infection which was parametrized by its median a and
mode b. Specifically, we used a log-normal density function trun-
cated at day 10 to represent this infectivity profile − we denoted the
effective median (i.e. half-life) of the infectivity profile after trun-
cation by aeff . Children and adults were assumed to have different
scaling factors βi to the infectivity profile (β1 and β2 for children and
adults respectively). We also assumed children were η1 times more
susceptible than adults. A coefficient was used to explain the depen-
dency between the infectiousness and household size. Consequently,
the hazard of infection Hk→j(t) exerted on a susceptible member j
by an infected member k was determined by coupling the infectivity
profile with the household size, the age and the time since infection of
member k. The total hazard of infection exerted on member j at time
t in the household was then taken to be the aggregated hazard of in-
fection H(t) from other infected members at time t in the household,
i.e.
H(t) =
n∑
k 6=j
Hk→j(t). [1]
We allowed a constant community infection hazard ρ common to chil-
dren and adults on top of the within-household hazard. Interventions
were assumed to reduce the magnitude of the infectivity profile by a
constant proportion ri, where i = 1, 2, 3 corresponded to the control,
HH and HH+FM arms respectively − since we were interested in the
efficacy of HH and HH+FM arms relative to the control arm, we set
r1 = 0. Interventions had no effect on the community infection.
A non-index case has a probability p to be an asymptomatic in-
fection. Given the infection time, onset time of a symptomatic case
was determined by an assumed incubation period parametrized by α
and γ. Also, for the robustness of the model, we had φ as a nuisance
parameter representing the background constant rate of non-infection
symptoms onset (Refs [35, 36]). The RT-PCR testing results were as-
sumed to depend on times of measurements, a (peak) test sensitivity
ψ and a test specificity Q. The test sensitivity was assumed to be a
(step-)function of the time since infection and peak around the mean
of the incubation period (also see SI for details). The test sensitivity of
asymptomatic infections was assumed to be half that of symptomatic
infections (see also different assumed values used in Sensitivity Anal-
ysis). Lastly, households were assumed to be independent given the
sparse recruitment.
Events above were also described mathematically in SI.
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Bayesian Inference and McMC. Let θ be the parameter vector con-
taining the model parameters described in last section. Estimation
for the model parameters was performed in the Bayesian framework
(i.e. we estimated the parameters from the posterior distributions for
the parameters). Denoting the observed data by x and the joint like-
lihood for all households by L(θ;x) respectively, the posterior dis-
tribution of parameters given x was P (θ|x) ∝ L(θ;x)pi(θ), where
pi(θ) was the assumed prior distribution for θ. We used marginal
non-informative uniform priors for individual parameters in θ (i.e.
pi(θi) ∼ U(c, d) where c and d represented conservative lower and
upper bound of θi). Markov chain Monte Carlo techniques [39] were
applied to obtain the posterior distribution, i.e we constructed the
Markov chain in such a way that the stationary distribution was the
posterior distribution P (θ|x) of interest. Details of the construction
of the likelihood function and of the McMC algorithm are given in SI
text.
Hidden Infection Process. Symptom onset and RT-PCR are not per-
fect indicators for an infection (e.g. the symptom onset might have
a different aetiology and the sensitivity of RT-PCR is only high at
the time of peak infectiousness [19, 20, 21]). To handle this uncer-
tainty and to capture more accurately the underlying transmission dy-
namics, we required an algorithm which allows proper probabilistic
transitions of a household member between the status of infected and
non-infected. Specifically, we applied a reversible jump algorithm
[40, 41] in which deletion (i.e. transit from infected to non-infected)
and addition (i.e. transit from non-infected to infected) of an infec-
tion is allowed. More details on the inference of times on infection
and how the process parameters and infection times were updated in
the same algorithm are given in SI text.
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